Shaun O’Brien

6.5k citations

44 papers · 4.9k indexed · 4 hit papers · h-index 22

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 21
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 10
- Immune cells in cancer 5
- T-cell and B-cell Immunology 5
Oncology 25
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 8

Co-authors: Steven Μ. Albelda Kheng Newick Edmund K. Moon Donald M. McDonald Barbara Sennino Michael R. Mancuso Rachel Davis Scott M. Norberg
Journals: Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Cancer Immunology Research (3 papers)Immunity (2 papers)OncoImmunology (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Shaun O’Brien

42 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

CAR T Cell Therapy for Solid Tumors 2016 · 663 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Annual Review of Medicine
2015 Cancer Research
2006 Journal of Clinical Investigation
2005 American Journal of Physiology-Heart and Circulatory Physiology

Peers

Countries citing papers authored by Shaun O’Brien

Since Specialization

Citations

This map shows the geographic impact of Shaun O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaun O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaun O’Brien more than expected).

Fields of papers citing papers by Shaun O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaun O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaun O’Brien. The network helps show where Shaun O’Brien may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shaun O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shaun O’Brien Line = papers co-authored together Shaun O’Brien links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nonredundant Immune Checkpoints Direct Therapeutic Resistance to Chemoimmunotherapy in Pancreatic Ductal Adenocarcinoma Cancer Immunology Research ·Meredith L. Stone, M. Matera, Philip G. Morrow, 贺建英, Jiangtao Huang, Kathleen Graham, K. (Kateřina) Sukačová, Albert T. Walker, Shaun O’Brien, Gregory L. Beatty	2025	0
2	Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors Journal for ImmunoTherapy of Cancer ·Blessie Elizabeth Nelson, Shaun O’Brien, Rahul A. Sheth, David S. Hong, Aung Naing, Xiao–Ping Zhang, Amy Xu, Lora Hamuro, Claudell Burnell, 侯文杰, Ruslan D. Novosiadly, Sarina A. Piha‐Paul	2025	6
3	Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032) Journal for ImmunoTherapy of Cancer ·Margaret K. Callahan, Asim Amin, Frederic J. Kaye, Michael A. Morse, Matthew H. Taylor, Katriina Peltola, Padmanee Sharma, Eileen M. O’Reilly, Анастасия Георгиевна Казначеева, Shaun O’Brien, Marina Tschaika, Dung T. Le	2024	7
4	First in human phase Ⅰ study of BMS-986299 as monotherapy and combined with nivolumab and ipilimumab in advanced solid tumors. Journal of Clinical Oncology ·Blessie Elizabeth Nelson, Rahul A. Sheth, Karen Kelly, Haeseong Park, Sandip Pravin Patel, 侯文杰, Shaun O’Brien, Mohammad miftahus sa'di, Sarina A. Piha‐Paul	2023	7
5	Broken guidewire retrieval from the hip joint: A case report Trauma Case Reports ·U.H. Pavlova, Shaun O’Brien	2021	3
6	Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes OncoImmunology ·Astero Klampatsa, Shaun O’Brien, Jeffrey C. Thompson, Abhishek Rao, Jason Stadanlick, Marina C. Martinez, Maria Liousia, Edward Cantu, Keith A. Cengel, Edmund K. Moon, Sunil Singhal, Evgeniy Eruslanov, Steven Μ. Albelda	2019	34
7	Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer Science Translational Medicine ·Sunil Singhal, Jason Stadanlick, Xavier Bernard Lopez, Abhishek Rao, Pratik Bhojnagarwala, Shaun O’Brien, Edmund K. Moon, Edward Cantu, Gwenn Danet-Desnoyers, Hyun-Jeong Ra, Leslie A. Litzky, Tatiana Akimova, Ulf H. Beier, Wayne W. Hancock, Steven Μ. Albelda, Evgeniy Eruslanov	2019	183
8	Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer Cancer Immunology Research ·Shaun O’Brien, Astero Klampatsa, Jeffrey C. Thompson, Marina C. Martinez, Wei‐Ting Hwang, Bartholomew Moore, Oziel Saturnino, Soyeon Kim, Edward Cantu, Leslie A. Litzky, Sunil Singhal, Evgeniy Eruslanov, Edmund K. Moon, Steven Μ. Albelda	2019	67
9	Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells Immunity ·Bertram Bengsch, Takuya Ohtani, Omar Khan, Manu Setty, Sasikanth Manne, Shaun O’Brien, Pier Federico Gherardini, Ramin S. Herati, Alexander C. Huang, Kyong‐Mi Chang, Evan W. Newell, Niels Bovenschen, Dana Pe’er, Steven Μ. Albelda, E. John Wherry	2018	183
10	Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization Cancer Immunology Research ·Kheng Newick, Shaun O’Brien, Jing Sun, Veena Kapoor, 何南熹, Albert Lo, Ellen Puré, Edmund K. Moon, Steven Μ. Albelda	2016	160
11	Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer Cancer Cell ·Sunil Singhal, Pratik Bhojnagarwala, Shaun O’Brien, Edmund K. Moon, Alfred L. Garfall, Abhishek S. Rao, Jon G. Quatromoni, Tom L. Stephen, Leslie A. Litzky, Charuhas Deshpande, Michael D. Feldman, Wayne W. Hancock, José R. Conejo-García, Steven Μ. Albelda, Evgeniy Eruslanov	2016	334
12	CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer Cancer Research ·Tatiana A. Karakasheva, Todd J. Waldron, Evgeniy Eruslanov, Sang-Bae Kim, Ju‐Seog Lee, Shaun O’Brien, Philip Hicks, Devraj Basu, Sunil Singhal, Fabio Malavasi, Anil K. Rustgi	2015	131
13	Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer Clinical Cancer Research ·Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O’Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, Steven Μ. Albelda	2015	96
14	Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark BMJ ·Seung‐Jae Lee, W. John Boscardin, Irena Stijacic‐Cenzer, Jessamyn Conell‐Price, Shaun O’Brien, Louise C. Walter	2012	170
15	The Use of a Revision Femoral Stem to Manage a Distal Femoral Periprosthetic Fracture in a Well-Fixed Total Knee Arthroplasty The Journal of Arthroplasty ·Richard Jeavons, Березин Ф.М, Shaun O’Brien	2011	2
16	Angiopoietin/Tie2 Signaling Transforms Capillaries into Venules Primed for Leukocyte Trafficking in Airway Inflammation American Journal Of Pathology ·Jonas Fuxe, Erin Lashnits, Shaun O’Brien, Peter Bałuk, Sébastien P. Tabruyn, Frank Kuhnert, Calvin J. Kuo, Gavin Thurston, Donald M. McDonald	2010	29
17	Compartment syndrome after low molecular weight heparin following lower limb blunt trauma: lessons for outpatient deep vein thrombosis protocols: Figure 1 BMJ Case Reports ·Березин Ф.М, S. Aldridge, Shaun O’Brien	2009	2
18	Decrease of Foxp3+ Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection Immunity ·Guillaume Oldenhove, Nicolas Bouladoux, Elizabeth A. Wohlfert, Jason A. Hall, David B. Chou, Liliane Martins dos Santos, Shaun O’Brien, Rebecca B. Blank, Erika Lamb, S. Natarajan, Robin J. Kastenmayer, Christopher A. Hunter, Michael E. Grigg, Yasmine Belkaid	2009	464
19	CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion Blood ·Brian D. Kavanagh, Shaun O’Brien, David Lee, Yafei Hou, Vivian Weinberg, Brian I. Rini, James P. Allison, Eric J. Small, Lawrence Fong	2008	201
20	Evaluation and comparison of three mobilization methods for the collection of granulocytes Transfusion ·Yulan Peng, Benjamin Lichtiger, E. Anaissie, K. Rajender Reddy, Shaun O’Brien, Hagop M. Kantarjian, Eun Seong Park	1998	44

About Shaun O’Brien

Shaun O’Brien is a scholar working on Immunology, Oncology, Neuropsychology and Physiological Psychology, Immunology and Allergy and Behavioral Neuroscience, having authored 44 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (8 papers), Immune cells in cancer (5 papers), T-cell and B-cell Immunology (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Orthopedic Infections and Treatments (3 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (2.6k citations), Cancer Research (513 citations), Molecular Biology (1.5k citations) and Pulmonary and Respiratory Medicine (630 citations). Shaun O’Brien has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Steven Μ. Albelda, Kheng Newick, Edmund K. Moon, Donald M. McDonald, Barbara Sennino, Michael R. Mancuso, Rachel Davis, Scott M. Norberg, Evgeniy Eruslanov and Sunil Singhal. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Immunology Research, Immunity and OncoImmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact